Access cutting-edge heart transplant treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access heart transplant specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart transplant treatment provided free
The purpose of this study is to compare the safety and efficacy of letermovir with valganciclovir for prevention of Cytomegalovirus (CMV) viremia in moderate to high risk serostatus heart transplant recipients.
Sponsor: Columbia University
Check if you qualify for this heart transplant clinical trial in New York, NY
If you're searching for heart transplant treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.